jump to content  sitemap
Center for Personalized Health Care
http://cphc.osu.edu//cphcnews.cfm

News

Home > News

Pharmacogenomics: When drug treatment becomes personalized medicine

Posted 6/30/2008

In medicine, one size doesn't fit all. Two people who take the same cancer medication, for instance, may have very different responses. One may have severe, even life-threatening side effects, while the other experiences few if any side effects and seems to sail through treatment. Or, the drug may shrink a tumor in one person but not in another. The rest of the story

------

The American Medical Association adopts policies on direct-to-consumer genetic testing

Posted 6/26/2008

The American Medical Association (AMA), the largest physician group in the US, held its Annual Meeting this month; among the policies adopted were recommendations relating to direct-to-consumer (DTC) advertising and provision of genetic tests (see press release). The rest of the story

------

Genetic-Testing Company Details Regulatory Defense Plan

Posted 6/26/2008

Genetic-testing company Navigenics has responded to the state of California's cease-and-desist letter with a novel defense: It doesn't actually test patients' genomes, it just analyzes 'em. The rest of the story

------

Human genome changes with age

Posted 6/26/2008

WASHINGTON (AFP) — Individual human genomes change throughout a person's life influenced by environmental or nutritional factors which may explain why illnesses such as cancer come with age, a study said Tuesday. The rest of the story

------

Genome testing firms defy state order to stop

Posted 6/26/2008

Consumer genome testing companies Navigenics Inc. and 23andMe refused orders Tuesday by the state Health Department to cease accepting California clients until they satisfy officials that their businesses comply with regulations governing clinical laboratories. The rest of the story

------

Gene Testing Questioned by Regulators

Posted 6/26/2008

Regulators are cracking down on companies that sell genetic tests directly to consumers, threatening to crimp the growth of one of the hottest sectors of the biotechnology industry. The rest of the story

------

Test to determine each woman's chances of breast cancer

Posted 6/26/2008

Scientists in Cambridge believe they are close to developing a test that will analyse each woman's genetic make-up and determine whether she is at high or low risk of the cancer. The rest of the story

------

Genetic Test Cease-And-Desist Notices

Posted 6/25/2008

The California Department of Public Health has issued notices to 13 laboratories to cease and desist performing genetic testing for California residents until the laboratories meet the requirements specified in state law. The rest of the story

------

Gene Mutation Improves Leukemia Drug's Effect

Posted 6/24/2008

Gene mutations that make cells cancerous can sometimes also make them more sensitive to chemotherapy. A new study led by cancer researchers at The Ohio State University shows that a mutation present in some cases of acute leukemia makes the disease more susceptible to high doses of a particular anticancer drug. The rest of the story

------

Turning personalized medicine into reality

Posted 6/24/2008

It's been a hot couple of years for genomics, the study of the long chain of chemicals that determines all the hereditary information in a person's DNA, from hair and eye color to propensity for disease. The rest of the story

------

Next

The Ohio State University
Center for Personalized Health Care
165 Prior Health Sciences Library | 376 W 10th Avenue | Columbus, OH 43210
ph: (614) 292-7424 | fx: (614) 688-5785